United StatesLidocaine Ointment USP, 5%, Speermint Flavor, 50 g jar (Rx only), Lot # AD48154, Exp. 4/30/2027, NDC 51672-3008-5, manufactured by Taro Pharmaceuticals and distributed by Taro Pharmaceuticals U.S.A., is being recalled. Sun Pharma/Taro recalled 65,328 jars sold nationwide in the USA after the product failed content uniformity specifications and was out of specification for assay during analysis at the 24‑month long‑term stability station (25°C, 60% RH).
What's being recalled
Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist By: Taro Pharmaceuticals U.S.A. Inc. Hawthorne NY 70532 NDC: 51672-3008-5
Recalling firm: Sun Pharma /Taro, Hawthorne, NY, United States.
How to identify it
Lot # AD48154, Exp: 4/30/2027.
The hazard
Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide in the USA
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)